APA (7th ed.) Citation

Mitra, D., Vega-Rubín-de-Celis, S., Royla, N., Bernhardt, S., Wilhelm, H., Tarade, N., . . . Wiemann, S. (2021). Abrogating GPT2 in triple-negative breast cancer inhibits tumor growth and promotes autophagy. International journal of cancer, 148(8), . https://doi.org/10.1002/ijc.33456

Chicago Style (17th ed.) Citation

Mitra, Devina, et al. "Abrogating GPT2 in Triple-negative Breast Cancer Inhibits Tumor Growth and Promotes Autophagy." International Journal of Cancer 148, no. 8 (2021). https://doi.org/10.1002/ijc.33456.

MLA (9th ed.) Citation

Mitra, Devina, et al. "Abrogating GPT2 in Triple-negative Breast Cancer Inhibits Tumor Growth and Promotes Autophagy." International Journal of Cancer, vol. 148, no. 8, 2021, https://doi.org/10.1002/ijc.33456.